Contents & References of QSAR study on pyrrolo[3,2-d]pyrimidine-7-carbonitrile derivatives for antidiabetic drugs
List:
Preface 1
Abstract. 2
Chapter One: Generalities
1-1- Introduction. 5
1-2- Chemometrics. 5
1-2-1- Applications of chemometrics. 6
1-3- The advantages of computational methods compared to laboratory methods. 6
1-4- QSAR. 7
1-5- Regression. 7
1-6- Parametric methods. 8
1-6-1- Single-variable and multi-variable calibration. 9
1-6-2- Classical Least Squares (CLS) 9
1-6-3- Inverse Least Squares (ILS) 9
1-6-4- Multiple Linear Regression (MLR) 9
1-6-5- Partial Least Squares (PLS) 10
1-6-6- Principal Component Analysis (PCA) 10
1-6-7-Principal component regression (PCR) 11
1-6-8- Non-linear multivariate regression (MNR) 12
1-6-9- Fuzzy logic. 12
1-6-9-1-Applications of fuzzy logic. 13
1-6-10- Artificial Neural Networks (ANN) 13
1-6-10-1- Features of neural network. 14
1-6-10-2- Advantages of neural network. 16
1-6-10-3- Neural network applications. 16
1-6-11- Genetic algorithm (GA) 17
1-6-11-1- Darwin's laws. 18
1-6-11-2- Features of genetic algorithm. 18
1-6-11-3- Strengths of genetic algorithms. 20
1-6-11-4- Limitations of genetic algorithms. 21
1-6-11-5- selection methods for genetic algorithm. 21
1-7- Diabetes. 22
1-7-1- Classification and etiology of diabetes. 23
1-7-1-1- Type one diabetes. 24
1-7-1-2- type two diabetes. 25
1-7-1-3- Gestational diabetes. 25
1-7-1-4- other types of diabetes. 26
1-8- Status of diabetes in the world. 29
1-9- Death caused by diabetes. 29
1-10- The costs of diabetes. 29
1-11- Diabetes prevention and control. 30
1-12- Medicines 30
1-12-1-Sulfonylureas 31
1-12-2- Biguanides 32
1-12-3- Acarbose 32
1-12-4- Thiazolidinediones (TZD) 33
1-12-5- Meglitinides 33
Chapter Two: Methodology
2-1- Drawing derivatives. 36
2-1-1- Add method and optimize derivatives. 36
2-1-2- Adding molecular descriptors to derivatives. 36
2-1-3- Making matrix and screening descriptors for derivatives. 37
2-1-4- GA calculations. 38
2-1-5- GA-ANN calculations. 39
2-1-6- Jackknife calculations. 39
2-1-7- GA-MLR calculations. 39
2-1-8- Analysis with PLS, PCR and MLR methods. 40
2-1-9- Analysis with GA-MCR, GA-PLS, GA-PCR, GA-MLR and GA-RS methods. 40
2-1-10- Predicting the structure 40
Second part: discussion and conclusion
2-2- Discussion and conclusion. 42
Suggestions for future work. 124
Sources and sources. 125
Source:
Abdi H, Williams L.J. "Principal component analysis". Wiley Interdisciplinary Reviews: Computational Statistics, 2 (2010) 433–459.
Ajmani S, Jadhav K, Kulkarni S, A. "Group-Based QSAR (G-QSAR): Mitigating Interpretation Challenges in QSAR". QSAR & Combinatorial Science, 28 (2008) 36–51.
Albert K. J, Lewis N. S, Schauer C. L, Sotzing G. A, Stitzel S. E, Vaid T. P, Walt D. R. Chem Rev. 100 (2000) 2595-2626.
Andersson C. A, Bro R. Journal Chemometrics, 14 (2000) 103.
Bertsekas D. P, Tsitsiklis J. N. Neuro-dynamic programming. Athena Scientific, 8 (1996) 512.
Bordogna G, Pasi G. Handling vagueness in information retrieval systems. In: Proceedings of the Second New Zealand International Two-Stream Conference on Artificial Neural Networks and Expert Systems, 20-23 (1995) 110-114.
Cano J. R, Herrera F, Lozano M. Using evolutionary algorithms as instance selection for data reduction in KDD: an experimental study. IEEE Transactions on Evolutionary Computation, 7 (2003) 561-575.
Christopher J. Cramer Essentials of Computational Chemistry, John Wiley & Sons, 45 (2002) 23.
Cox D. R. Principles of Statistical Inference, Cambridge University Press, 2 (2006) 521.
Diabetes Blue Circle Symbol. . International Diabetes Federation, 17 March 2006
Diagnosis and Classification of Diabetes Mellitus". Diabetes Care 33Diabetes Care 33 (Supplement_1): S62–S69. 2009. DOI:10.2337/dc10-S062. ISSN 0149-5992.
E.A.M. Gale. "Drug-induced diabetes". European Association for the Study of Diabetes.
Eiben E, Hinterding R, Michalewicz Z. "Parameter Control in Evolutionary Algorithms", IEEE Transactions on Evolutionary Computation, IEEE, 3 (1999) 124-141
Fraser A. "Simulation of genetic systems by automatic digital computers. I. Introduction". Aust. J. Biol. Sci, 10 (1957) 484–491.
Galleri, L.; Sebastiani, G.; Vendrame, F.; Grieco, FA.; Spagnuolo, I.; Dotta, F. (2012). "Viral infections and diabetes." Adv Exp Med Biol 771: 252-71. PMID 23393684
Galton F. "Kinship and Correlation (reprinted 1989)". Statistical Science (Institute of Mathematical Statistics), 4 (1989) 80–86.
Geladi P, Esbensen K. The start and early history of chemometrics: Journal Chemometrics, 4 (2005) 337–354.
Henzen C (2012). "Monogenic diabetes mellitus due to defects in insulin secretion". Swiss Med Wkly 142: w13690. DOI:10.4414/smw.2012.13690. PMID 23037711
Hopfield J. Neural networks and physical systems with emergent collective computational abilities. Proc. NatL Acad. Sci. USA Vol. 79 (1982) 2554-2558.
Lambert, Paul; Bingley, Polly J (2002). "What is Type 1 Diabetes?". Medicine 30 (1): 1–5. DOI: 10.1383/medc.30.1.1.28264. ISSN 13573039
Lee, A. J.; Hiscock, R. J.; Wein, P.; Walker, S. P.; Permezel, M. (2007). "Gestational Diabetes Mellitus: Clinical Predictors and Long-Term Risk of Developing Type 2 Diabetes: A retrospective cohort study using survival analysis". Diabetes Care 30(4):878–883. DOI:10.2337/dc06-1816. ISSN 0149-5992
Lin S. Computer solutions of the traveling salesman problem. Bell Systems Tech, 44 (1965) 2245–2269.
Maraschin, Jde F. (2012). "Classification of diabetes." Adv Exp Med Biol 771: 12-9. PMID 23393666
Massy W. F. Principal components regression in exploratory statistical research. J. Amer. Stat. Assoc, 60 (1965) 234-256.
McMinn P. Search-based Software Test Data Generation: A Survey. Journal of Software Testing Verification and Reliability, 14 (2004) 105-156.
Melanitou, Evie; Fain, Pam; Eisenbarth, George S (2003). "Genetics of Type 1A (immune mediated) diabetes". Journal of Autoimmunity 21 (2): 93–98. DOI:10.1016/S0896-8411(03)00097-0. ISSN 08968411
Metzger, B. E.; Buchanan, T. A.; Coustan, D.R.; de Leiva, A.; Dunger, D.B.; Hadden, D.R.; Hod, M.; Kitzmiller, J.L. et al (2007). "Summary and Recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus". Diabetes Care 30 (Supplement_2): S251–S260. DOI:10.2337/dc07-s225. ISSN 0149-5992
Neubig R. R. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification.
Northcutt W. The Darwin Awards: Evolution in Action. New York City: PLUME (The Penguin Group). 5 (2000) 2-6.
Resmini, Eugenia; Minuto, Francesco; Colao, Annamaria; Ferrone, Diego (2009). "Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities". Acta Diabetologica 46 (2): 85–95. DOI:10.1007/s00592-009-0112-9. ISSN 0940-5429
Ross G (June 2006). "Gestational diabetes". Aust Fam Physician 35 (6): 392–6. PMID 16751853
Roy P. P, Leonard J. T, Roy K. "Exploring the impact of size of training sets for the development of predictive QSAR models". Chemometrics and Intelligent Laboratory Systems, 90 (2008) 31–42.
Sampson UK, Linton MF, Fazio S (July 2011). "Are statins diabetogenic?". Curr. Opin. Cardiol. 26 (4): 342–7. DOI:10.1097/HCO.0b013e3283470359. PMC 3341610. PMID 21499090
Schafer, Andrew I. ; Lee A. Fleisher MD (2011). Goldman's Cecil Medicine: Expert Consult Premium Edition - Enhanced Online Features and Print, Single Volume (Cecil Textbook of Medicine). Philadelphia: Saunders. pp. e237-1. ISBN 1-4377-1604-0
Schafer, Andrew I